We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Protein Fragments Protect Against Botulinum Toxin

By Biotechdaily staff writers
Posted on 14 Oct 2003
Researchers have identified the molecules that bind and transport botulinum toxin (BoNT), a bacterial toxin that causes paralysis and is extremely toxic even at very low concentrations.

Previous research had shown that complex cell membrane glycolipids known as gangliosides were involved along with some proteins in the internalization of botulinum toxin. More...
Investigators at the University of Wisconsin (Madison, USA; www.wisc.edu) employed both tissue culture and animal experiments to identify the protein component.

The investigators reported in a study published in the September 29, 2003, issue of the Journal of Cell Biology that they used gain-of-function and loss-of-function approaches to show that the secretory vesicle proteins, synaptotagmins (syts) I and II, mediated the entry of BoNT/B (but not BoNT/A or E) into PC12 tissue culture cells. They also demonstrated that BoNT/B entry into PC12 cells and rat diaphragm motor nerve terminals was activity dependent and could be blocked using fragments of syt II that contain the BoNT/B-binding domain. Finally, they showed that syt II fragments, in conjunction with gangliosides, neutralized BoNT/B in intact mice.

Senior author Dr. Edwin Chapman, professor of physiology at the University of Wisconsin explained, "The fragments are a protective agent, a scavenger, that prevents the toxin from reaching its target.”



Related Links:
University of Wisconsin

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Aspiration System
VACUSAFE
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.